References
- Linden P, Kusne S, Coley K, Fontes Paulo, Kramer D, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial resistant Pseudomonas aeruginosa. Clin Infect Dis. 2003; 37: e154–e160.
- Markou N, Apostolakos H, Koumovelious C, Athanasiou M, Koutsoukou A, Alamanso I, Gregorakos L. Intravenous col-istin in the treatment of sepsis from multiresistant gram-nega-tive bacilli in critically ill patients. Crit Care 2003; 7 (5): R78–R83.
- Rynn C, Wooitan M, Bowker KE, Alan Hola H, Reeves DS. In vitro assessment of colistin antipseudomanl antimicro-bial interactions with other antibiotics. Clin Microbiol Infect 1999; 5 (1): 32–36.
- Gunderson BW, Khalid Ibrahim, Hovde L, Timothy LF, Reed M, Rotschafer JC. Synergistic activity of colistin and cef-tazidime against multiantibiotic resistant Pseudomonas aerugi-nosa in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2003; 905–909.
- Giamarellos-Bourboulis EJ, Sambutakou H, Galani I, Giamarellous H. In vitro interaction of colistin and rifampin on multidrug resistant Pseudomonas aeruginosa. J Chemother 2003; 15 (3): 235–8.
- Lorian V. Antibiotics in laboratory medicine. Barry AL ed. Procedure and theoretical consideration for testing antimi-crobial agents in agar media. III edition. Baltimore: William and Wilkins, 1991: 1–16.
- Lorian V. Antibiotics in laboratory medicine. In: Krogstad DJ, Moellering RC. eds. Combination of antibiotics, mechanism of interaction against bacteria. New York 1980; 305-306.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility test. 12th informational supplement. NCCLS document M100-S12. Wayne, PA: NCCLS, 2002
- Gales A, Reis A, Jones R. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and qual-ity control guidelines. J Clin Microbiol 2001; 39: (1) 83–190.
- Levin AS, Barone AA, Penco J, et al. Intravenous col-istin as therapy for nosocomial infection caused by multidrug resistant Pseudomonas aeruginosa and Acinetobacter bau-mannii. Clin Infect Dis 1999; 28: 1008.
- Falagas ME, Bliziotis IA, Kasiakou SK, Panayiota A, Michalopoulos A. Outcome of infections due to pandrug-resis-tant (PDR) gram negative bacteria. BMC Infect Dis 2005; 5:24.